Free Newsletter
Vermont docs received more secret payments
A March 2007 article in the Journal of the American Medical Association told the story of pharma companies paying physicians in Vermont over $2.7 million between July 2002 and June 2004, but the advocacy group that reported the original findings now says the amount is actually much higher.
According to the organization Public Citizen, the payments total nearly $5 million and "strongly suggest" violations of American Medical Association and PhRMA professional guidelines, which restrict said payments to $100 per doctor, per occassion.
In fact, the group found that more than $3.2 million worth of the payments were greater than $100 each, representing nearly 90 percent of the payments to physicians by drug companies. Twenty-one drugmakers were said to have kept the payments under wraps. The companies involved included Abbott Labs, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Merck and Roche.
- see the full story at Pharmalot
Related Articles:
Lilly tops VT's doc-marketing list
Psych docs mull ties with drugmakers
Arms twisted, pharma promises disclosure
Docs go cold turkey on industry pay
Arms twisted, pharma promises disclosure
Americans want doc payments disclosed
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: